These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8860280)

  • 1. Pap smear screening in a health maintenance organization: 1986-1990.
    Rolnick S; LaFerla JJ; Wehrle D; Trygstad E; Okagaki T
    Prev Med; 1996; 25(2):156-61. PubMed ID: 8860280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pap smear screening among urban Southwestern American Indian women.
    Risendal B; DeZapien J; Fowler B; Papenfuss M; Giuliano A
    Prev Med; 1999 Dec; 29(6 Pt 1):510-8. PubMed ID: 10600432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pap screening in a U.S. health plan.
    Insinga RP; Glass AG; Rush BB
    Cancer Epidemiol Biomarkers Prev; 2004 Mar; 13(3):355-60. PubMed ID: 15006908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for cervical disease in mature women: strategies for improvement.
    Colgan TJ; Clarke A; Hakh N; Seidenfeld A
    Cancer; 2002 Aug; 96(4):195-203. PubMed ID: 12209660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of adding human papilloma virus testing to a managed care cervical cancer screening program.
    Lonky NM; Hunter MI; Sadeghi M; Edwards G; Bajamundi K; Monk BJ
    J Low Genit Tract Dis; 2007 Oct; 11(4):258-64. PubMed ID: 17917570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process.
    Leyden WA; Manos MM; Geiger AM; Weinmann S; Mouchawar J; Bischoff K; Yood MU; Gilbert J; Taplin SH
    J Natl Cancer Inst; 2005 May; 97(9):675-83. PubMed ID: 15870438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of cervical cancer screening program at a rural community of South Africa.
    Hoque M; Hoque E; Kader SB
    East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Papanicolaou smear history and diagnosis of invasive cervical carcinoma among members of a large prepaid health plan.
    Sung HY; Kearney KA; Miller M; Kinney W; Sawaya GF; Hiatt RA
    Cancer; 2000 May; 88(10):2283-9. PubMed ID: 10820350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervical cancer screening in a rural population of Zimbabwe.
    Thistle PJ; Chirenje ZM
    Cent Afr J Med; 1997 Sep; 43(9):246-51. PubMed ID: 9509642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
    Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
    J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hispanic acculturation and utilization of cervical cancer screening in the US.
    Shah M; Zhu K; Wu H; Potter J
    Prev Med; 2006 Feb; 42(2):146-9. PubMed ID: 16297444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pap test--with or without vaginal smear?
    Milicić-Juhas V; Perić M; Pajtler M; Prvulović I; Curzik D
    Coll Antropol; 2010 Mar; 34(1):69-74. PubMed ID: 20437636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Educational level and cervical cancer screening programs in a Venezuelan urban area.
    Núñez-Troconis J; Velásquez J; Mindiola R; Munroe D
    Invest Clin; 2008 Sep; 49(3):331-9. PubMed ID: 18846774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervical cancer screening among elderly urban women in a primary care setting.
    Wong QC; Collins R; Kalkstein K; Roth A; Gintautas J
    Proc West Pharmacol Soc; 2005; 48():154-6. PubMed ID: 16416686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
    Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
    BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of a new cervical pap smear screening guideline on member perceptions and comfort levels.
    Rolnick SJ; LaFerla JJ; Jackson J; Akkerman D; Compo R
    Prev Med; 1999 May; 28(5):530-4. PubMed ID: 10329344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Papanicolaou smear screening of women with intellectual disabilities: a cross-sectional survey in Taiwan.
    Lin LP; Lin JD; Sung CL; Liu TW; Liu YL; Chen LM; Chu CM
    Res Dev Disabil; 2010; 31(2):403-9. PubMed ID: 19897337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cervical cancer screening in medically underserved California Latina and non-Latina women: effect of age and regularity of Pap testing.
    Howell LP; Gurusinghe S; Tabnak F; Sciortino S
    Cancer Detect Prev; 2009; 32(5-6):372-9. PubMed ID: 19264426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of Pap test history and histologically determined cervical cancer in NSW women, 1997-2003.
    Morrell S; Taylor R; Wain G
    J Med Screen; 2005; 12(4):190-6. PubMed ID: 16417696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cervical cytology screening. How can we improve rates among First Nations women in urban British Columbia?
    Hislop TG; Clarke HF; Deschamps M; Joseph R; Band PR; Smith J; Le N; Atleo R
    Can Fam Physician; 1996 Sep; 42():1701-8. PubMed ID: 8828873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.